Takeaway
Levels of different forms of salivary alpha-synuclein can distinguish people with Parkinson’s disease (PD) from Progressive Supranuclear Palsy (PSP).
Why this matters
Alpha-synuclein is an easily accessible biomarker which may be able to distinguish PD from PSP and correlate neurodegeneration with clinical findings.